Professor Fuad Fares is an Israeli biologist and pharmacologist of Druze descent. He is an Associate Professor and Director of the Molecular Genetics Laboratory at the University of Haifa, as well as Director of the Genetics Laboratory at Carmel Medical Center.
An entrepreneur in the field of biotechnology, Professor Fares was also a partner and one of the key figures who led research and development at Prolor Biotech, a biomedical company.

Professor Fuad Fares was born in the village of Hurfeish, Israel. He earned his Bachelor’s degree in Biology from the Hebrew University of Jerusalem in 1977, followed by a Master’s degree in Medical Sciences from the Technion – Israel Institute of Technology in 1983. In 1987, he completed his Ph.D. in Pharmacology at the Technion.
He conducted his postdoctoral research at the Laboratory of Pharmacology and Molecular Biology at Washington University in St. Louis, Missouri, USA.
Professor Fares currently serves as an Associate Professor in the Department of Human Biology at the University of Haifa.

Professor Fuad Fares is a member of the Council for Higher Education in Israel, where he serves on several subcommittees, including the Subcommittee on Technology and Engineering, the Subcommittee on Quality Assessment and Assurance, and the Subcommittee on Expanding Access to Higher Education for the Arab Community.
Professor Fares was also one of the founders of Prolor Biotech, a publicly traded biotechnology company, and served on its Board of Directors.
In April 2013, Fares and his partners sold their holdings in Prolor Biotech to OPKO Health through a stock-based transaction.

Professor Fuad Fares leads the botanical drug development project at Cannabotech, a biotechnology company. The project involves isolating a molecule found in a unique species of fungus and combining it with cannabinoids derived from cannabis.
This innovative approach is being investigated for its potential to target and destroy cancer cells associated with colorectal and pancreatic cancers.
Professor Fares works on this project alongside his son, Dr. Bassem Fares, a graduate of the Faculty of Medicine at the Technion – Israel Institute of Technology.

(Source: Wikipedia)